Cargando…
Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies
BACKGROUND: Although immune system plays a key role in the pathogenesis of both endometriosis and ovarian cancer, its function is different. Therefore, we hypothesized, that selected immune parameters can serve as diagnostic markers of these two conditions. The aim of this study was to compare serum...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381140/ https://www.ncbi.nlm.nih.gov/pubmed/28376925 http://dx.doi.org/10.1186/s13048-017-0320-9 |
_version_ | 1782519880324481024 |
---|---|
author | Sipak-Szmigiel, Olimpia Włodarski, Piotr Ronin-Walknowska, Elżbieta Niedzielski, Andrzej Karakiewicz, Beata Słuczanowska-Głąbowska, Sylwia Laszczyńska, Maria Malinowski, Witold |
author_facet | Sipak-Szmigiel, Olimpia Włodarski, Piotr Ronin-Walknowska, Elżbieta Niedzielski, Andrzej Karakiewicz, Beata Słuczanowska-Głąbowska, Sylwia Laszczyńska, Maria Malinowski, Witold |
author_sort | Sipak-Szmigiel, Olimpia |
collection | PubMed |
description | BACKGROUND: Although immune system plays a key role in the pathogenesis of both endometriosis and ovarian cancer, its function is different. Therefore, we hypothesized, that selected immune parameters can serve as diagnostic markers of these two conditions. The aim of this study was to compare serum and peritoneal fluid concentrations of sHLA-G, IL-10 and TNF-alpha in women with selected ovarian pathologies: benign serous cysts, endometrioma and malignant tumors. Clinical significance of using them for diagnostic purposes in women with serous ovarian cysts, endometriosis, and ovarian cancer, which in the future may improve the early diagnosis of ovarian diseases. CASE PRESENTATION: The study included women treated surgically for benign serous ovarian cysts, ovarian endometrioma and serous ovarian adenocarcinomas. Peripheral blood and peritoneal fluid samples were obtained intraoperatively. Patients with benign serous cysts, endometrioma and ovarian malignancies did not differ significantly in terms of their serum and peritoneal fluid concentrations of sHLA-G. Ovarian cancer patients presented with significantly higher median serum concentrations of IL-10 and TNF-alpha than other study subjects. Median concentrations of IL-10 and TNF-alpha in peritoneal fluid turned out to be the highest in ovarian cancer patients, followed by women with endometrioma and subjects with benign serous cysts. All these intergroup differences were statistically significant. Irrespective of the group, median concentrations of sHLA-G, IL-10 and TNF-alpha in peritoneal fluid were higher than serum levels of these markers. CONCLUSIONS: Elevated serum and peritoneal fluid concentrations of IL-10 and TNF-alpha distinguish ovarian malignancies and endometriomas from benign serous ovarian cysts. In contrast to endometriosis, ovarian malignancies are characterized by elevated peritoneal fluid concentrations of IL-10 and TNF-alpha, elevated serum concentrations of IL-10 and low serum levels of TNF-alpha. Serum and peritoneal fluid concentrations of sHLA-G have no diagnostic value in differentiating between ovarian malignancies and endometriomas. |
format | Online Article Text |
id | pubmed-5381140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53811402017-04-10 Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies Sipak-Szmigiel, Olimpia Włodarski, Piotr Ronin-Walknowska, Elżbieta Niedzielski, Andrzej Karakiewicz, Beata Słuczanowska-Głąbowska, Sylwia Laszczyńska, Maria Malinowski, Witold J Ovarian Res Case Report BACKGROUND: Although immune system plays a key role in the pathogenesis of both endometriosis and ovarian cancer, its function is different. Therefore, we hypothesized, that selected immune parameters can serve as diagnostic markers of these two conditions. The aim of this study was to compare serum and peritoneal fluid concentrations of sHLA-G, IL-10 and TNF-alpha in women with selected ovarian pathologies: benign serous cysts, endometrioma and malignant tumors. Clinical significance of using them for diagnostic purposes in women with serous ovarian cysts, endometriosis, and ovarian cancer, which in the future may improve the early diagnosis of ovarian diseases. CASE PRESENTATION: The study included women treated surgically for benign serous ovarian cysts, ovarian endometrioma and serous ovarian adenocarcinomas. Peripheral blood and peritoneal fluid samples were obtained intraoperatively. Patients with benign serous cysts, endometrioma and ovarian malignancies did not differ significantly in terms of their serum and peritoneal fluid concentrations of sHLA-G. Ovarian cancer patients presented with significantly higher median serum concentrations of IL-10 and TNF-alpha than other study subjects. Median concentrations of IL-10 and TNF-alpha in peritoneal fluid turned out to be the highest in ovarian cancer patients, followed by women with endometrioma and subjects with benign serous cysts. All these intergroup differences were statistically significant. Irrespective of the group, median concentrations of sHLA-G, IL-10 and TNF-alpha in peritoneal fluid were higher than serum levels of these markers. CONCLUSIONS: Elevated serum and peritoneal fluid concentrations of IL-10 and TNF-alpha distinguish ovarian malignancies and endometriomas from benign serous ovarian cysts. In contrast to endometriosis, ovarian malignancies are characterized by elevated peritoneal fluid concentrations of IL-10 and TNF-alpha, elevated serum concentrations of IL-10 and low serum levels of TNF-alpha. Serum and peritoneal fluid concentrations of sHLA-G have no diagnostic value in differentiating between ovarian malignancies and endometriomas. BioMed Central 2017-04-04 /pmc/articles/PMC5381140/ /pubmed/28376925 http://dx.doi.org/10.1186/s13048-017-0320-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Sipak-Szmigiel, Olimpia Włodarski, Piotr Ronin-Walknowska, Elżbieta Niedzielski, Andrzej Karakiewicz, Beata Słuczanowska-Głąbowska, Sylwia Laszczyńska, Maria Malinowski, Witold Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies |
title | Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies |
title_full | Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies |
title_fullStr | Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies |
title_full_unstemmed | Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies |
title_short | Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies |
title_sort | serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381140/ https://www.ncbi.nlm.nih.gov/pubmed/28376925 http://dx.doi.org/10.1186/s13048-017-0320-9 |
work_keys_str_mv | AT sipakszmigielolimpia serumandperitonealfluidconcentrationsofsolublehumanleukocyteantigentumornecrosisfactoralphaandinterleukin10inpatientswithselectedovarianpathologies AT włodarskipiotr serumandperitonealfluidconcentrationsofsolublehumanleukocyteantigentumornecrosisfactoralphaandinterleukin10inpatientswithselectedovarianpathologies AT roninwalknowskaelzbieta serumandperitonealfluidconcentrationsofsolublehumanleukocyteantigentumornecrosisfactoralphaandinterleukin10inpatientswithselectedovarianpathologies AT niedzielskiandrzej serumandperitonealfluidconcentrationsofsolublehumanleukocyteantigentumornecrosisfactoralphaandinterleukin10inpatientswithselectedovarianpathologies AT karakiewiczbeata serumandperitonealfluidconcentrationsofsolublehumanleukocyteantigentumornecrosisfactoralphaandinterleukin10inpatientswithselectedovarianpathologies AT słuczanowskagłabowskasylwia serumandperitonealfluidconcentrationsofsolublehumanleukocyteantigentumornecrosisfactoralphaandinterleukin10inpatientswithselectedovarianpathologies AT laszczynskamaria serumandperitonealfluidconcentrationsofsolublehumanleukocyteantigentumornecrosisfactoralphaandinterleukin10inpatientswithselectedovarianpathologies AT malinowskiwitold serumandperitonealfluidconcentrationsofsolublehumanleukocyteantigentumornecrosisfactoralphaandinterleukin10inpatientswithselectedovarianpathologies |